Capricor Therapeutics, Inc.
CAPR· Nasdaq
Released Aug 13, 2026, after the close
10-Q filed Aug 14, 2026, 45 days after period end · 0001104659-26-097294
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | — | — | $3.97M | $3.92M |
| Net Income | -$40.73M | -$25.91M | -$11.00M | -$7.37M |
| EPS Diluted |
Capricor Therapeutics, Inc. · CIK 1133869 · Engraved from SEC EDGAR
| -$0.70 |
| -$0.57 |
| -$0.35 |
| -$0.29 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.